{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:09:06Z","timestamp":1779361746392,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s11064-018-2505-z","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T13:59:09Z","timestamp":1521035949000},"page":"995-1002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Assessment of the Anticonvulsant Potency of Ursolic Acid in Seizure Threshold Tests in Mice"],"prefix":"10.1007","volume":"43","author":[{"given":"Dorota","family":"Nieoczym","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Soca\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"2505_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ejmech.2015.01.031","volume":"92","author":"H Chen","year":"2015","unstructured":"Chen H, Gao Y, Wang A, Zhou X, Zheng Y, Zhou J (2015) Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents. Eur J Med Chem 92:648\u2013655","journal-title":"Eur J Med Chem"},{"key":"2505_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.lfs.2016.01.017","volume":"146","author":"D Kashyap","year":"2016","unstructured":"Kashyap D, Tuli HS, Sharma AK (2016) Ursolic acid (UA): a metabolite with promising therapeutic potential. Life Sci 146:201\u2013213","journal-title":"Life Sci"},{"key":"2505_CR3","doi-asserted-by":"publisher","first-page":"20614","DOI":"10.3390\/molecules201119721","volume":"20","author":"L Wo\u017aniak","year":"2015","unstructured":"Wo\u017aniak L, Sk\u0105pska S, Marsza\u0142ek K (2015) Ursolic acid-a pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules 20:20614\u201320641","journal-title":"Molecules"},{"key":"2505_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pbb.2013.07.020","volume":"110","author":"J Verano","year":"2013","unstructured":"Verano J, Gonzalez-Trujano ME, Deciga-Campos M, Ventura-Martinez R, Pellicer F (2013) Ursolic acid from Agastache mexicana aerial parts produces antinociceptive activity involving TRPV1 receptors, cGMP and a serotonergic synergism. Pharmacol Biochem Behav 110:255\u2013264","journal-title":"Pharmacol Biochem Behav"},{"key":"2505_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/fcp.12223","volume":"30","author":"RA Bhat","year":"2016","unstructured":"Bhat RA, Lingaraju MC, Pathak NN, Kalra J, Kumar D, Kumar D, Tandan SK (2016) Effect of ursolic acid in attenuating chronic constriction injury-induced neuropathic pain in rats. Fundam Clin Pharmacol 30:517\u2013528","journal-title":"Fundam Clin Pharmacol"},{"key":"2505_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pbb.2014.05.015","volume":"124","author":"AR Colla","year":"2014","unstructured":"Colla AR, Oliveira A, Pazini FL, Rosa JM, Manosso LM, Cunha MP, Rodrigues AL (2014) Serotonergic and noradrenergic systems are implicated in the antidepressant-like effect of ursolic acid in mice. Pharmacol Biochem Behav 124:108\u2013116","journal-title":"Pharmacol Biochem Behav"},{"key":"2505_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.pbb.2012.08.016","volume":"103","author":"DG Machado","year":"2012","unstructured":"Machado DG, Neis VB, Balen GO, Colla A, Cunha MP, Dalmarco JB, Pizzolatti MG, Prediger RD, Rodrigues AL (2012) Antidepressant-like effect of ursolic acid isolated from Rosmarinus officinalis L. in mice: evidence for the involvement of the dopaminergic system. Pharmacol Biochem Behav 103:204\u2013211","journal-title":"Pharmacol Biochem Behav"},{"key":"2505_CR8","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.pharep.2017.05.009","volume":"69","author":"AB Ramos-Hryb","year":"2017","unstructured":"Ramos-Hryb AB, Cunha MP, Pazini FL, Lieberknecht V, Prediger RD, Kaster MP, Rodrigues AL (2017) Ursolic acid affords antidepressant-like effects in mice through the activation of PKA, PKC, CAMK-II and MEK1\/2. Pharmacol Rep 69:1240\u20131246","journal-title":"Pharmacol Rep"},{"key":"2505_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejphar.2015.03.077","volume":"758","author":"AR Colla","year":"2015","unstructured":"Colla AR, Rosa JM, Cunha MP, Rodrigues AL (2015) Anxiolytic-like effects of ursolic acid in mice. Eur J Pharmacol 758:171\u2013176","journal-title":"Eur J Pharmacol"},{"key":"2505_CR10","doi-asserted-by":"crossref","first-page":"1215393","DOI":"10.1155\/2016\/1215393","volume":"2016","author":"I Khan","year":"2016","unstructured":"Khan I, Karim N, Ahmad W, Abdelhalim A, Chebib M (2016) GABA-A receptor modulation and anticonvulsant, anxiolytic, and antidepressant activities of constituents from Artemisia indica Linn. Evid Based Complement Altern Med 2016:1215393","journal-title":"Evid Based Complement Altern Med"},{"key":"2505_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1755-5949.2012.00351.x","volume":"18","author":"I Kazmi","year":"2012","unstructured":"Kazmi I, Gupta G, Afzal M, Rahman M, Anwar F (2012) Pharmacological evaluation of anxiolytic activity of ursolic acid stearoyl glucoside isolated from Lantana camara. CNS Neurosci Ther 18:707\u2013708","journal-title":"CNS Neurosci Ther"},{"key":"2505_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ejphar.2015.06.037","volume":"762","author":"SJ Jeon","year":"2015","unstructured":"Jeon SJ, Park HJ, Gao Q, Pena IJ, Park SJ, Lee HE, Woo H, Kim HJ, Cheong JH, Hong E, Ryu JH (2015) Ursolic acid enhances pentobarbital-induced sleeping behaviors via GABAergic neurotransmission in mice. Eur J Pharmacol 762:443\u2013448","journal-title":"Eur J Pharmacol"},{"key":"2505_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2015.12.002","volume":"71","author":"SN Rai","year":"2016","unstructured":"Rai SN, Yadav SK, Singh D, Singh SP (2016) Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. J Chem Neuroanat 71:41\u201349","journal-title":"J Chem Neuroanat"},{"key":"2505_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.nlm.2011.03.010","volume":"96","author":"YJ Wang","year":"2011","unstructured":"Wang YJ, Lu J, Wu DM, Zheng ZH, Zheng YL, Wang XH, Ruan J, Sun X, Shan Q, Zhang ZF (2011) Ursolic acid attenuates lipopolysaccharide-induced cognitive deficits in mouse brain through suppressing p38\/NF-kappaB mediated inflammatory pathways. Neurobiol Learn Mem 96:156\u2013165","journal-title":"Neurobiol Learn Mem"},{"key":"2505_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.taap.2013.04.038","volume":"271","author":"DM Wu","year":"2013","unstructured":"Wu DM, Lu J, Zhang YQ, Zheng YL, Hu B, Cheng W, Zhang ZF, Li MQ (2013) Ursolic acid improves domoic acid-induced cognitive deficits in mice. Toxicol Appl Pharmacol 271:127\u2013136","journal-title":"Toxicol Appl Pharmacol"},{"key":"2505_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1590\/0004-282x20160065","volume":"74","author":"W Liang","year":"2016","unstructured":"Liang W, Zhao X, Feng J, Song F, Pan Y (2016) Ursolic acid attenuates beta-amyloid-induced memory impairment in mice. Arq Neuropsiquiatr 74:482\u2013488","journal-title":"Arq Neuropsiquiatr"},{"key":"2505_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.brainres.2012.12.032","volume":"1497","author":"L Li","year":"2013","unstructured":"Li L, Zhang X, Cui L, Wang L, Liu H, Ji H, Du Y (2013) Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice. Brain Res 1497:32\u201339","journal-title":"Brain Res"},{"key":"2505_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/ptr.2076","volume":"21","author":"MF Taviano","year":"2007","unstructured":"Taviano MF, Miceli N, Monforte MT, Tzakou O, Galati EM (2007) Ursolic acid plays a role in Nepeta sibthorpii Bentham CNS depressing effects. Phytother Res 21:382\u2013385","journal-title":"Phytother Res"},{"key":"2505_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1755-5949.2012.00369.x","volume":"18","author":"I Kazmi","year":"2012","unstructured":"Kazmi I, Afzal M, Gupta G, Anwar F (2012) Antiepileptic potential of ursolic acid stearoyl glucoside by GABA receptor stimulation. CNS Neurosci Ther 18:799\u2013800","journal-title":"CNS Neurosci Ther"},{"key":"2505_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2017.04.010","volume":"326","author":"K Soca\u0142a","year":"2017","unstructured":"Soca\u0142a K, Nieoczym D, Kowalczuk-Vasilev E, Wyska E, Wla\u017a P (2017) Increased seizure susceptibility and other toxicity symptoms following acute sulforaphane treatment in mice. Toxicol Appl Pharmacol 326:43\u201353","journal-title":"Toxicol Appl Pharmacol"},{"key":"2505_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","volume":"47","author":"ME Barton","year":"2001","unstructured":"Barton ME, Klein BD, Wolf HH, White HS (2001) Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47:217\u2013227","journal-title":"Epilepsy Res"},{"key":"2505_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/3570549","volume":"7","author":"AW Kimball","year":"1957","unstructured":"Kimball AW, Burnett WT Jr, Doherty DG (1957) Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice. Radiat Res 7:1\u201312","journal-title":"Radiat Res"},{"key":"2505_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000134913","volume":"3","author":"JR Boissier","year":"1960","unstructured":"Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle methode simple pour explorer l\u2019action \u201ctranquillisante\u201d: le test de la cheminee. Med Exp (Basel) 3:81\u201384","journal-title":"Med Exp (Basel)"},{"key":"2505_CR24","first-page":"233","volume":"1","author":"OA Meyer","year":"1979","unstructured":"Meyer OA, Tilson HA, Byrd WC, Riley MT (1979) A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1:233\u2013236","journal-title":"Neurobehav Toxicol"},{"key":"2505_CR25","doi-asserted-by":"crossref","first-page":"5.22.1","DOI":"10.1002\/0471141755.ph0522s45","volume":"45","author":"WJ Giardina","year":"2009","unstructured":"Giardina WJ, Gasior M (2009) Acute seizure tests in epilepsy research: electroshock- and chemical-induced convulsions in the mouse. Curr Protoc Pharmacol 45:5.22.1\u20135.22.37","journal-title":"Curr Protoc Pharmacol"},{"key":"2505_CR26","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1007\/s11064-017-2275-z","volume":"42","author":"JH Kehne","year":"2017","unstructured":"Kehne JH, Klein BD, Raeissi S, Sharma S (2017) The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP). Neurochem Res 42:1894\u20131903","journal-title":"Neurochem Res"},{"key":"2505_CR27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","volume":"52","author":"W L\u00f6scher","year":"2011","unstructured":"L\u00f6scher W, Schmidt D (2011) Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 52:657\u2013678","journal-title":"Epilepsia"},{"key":"2505_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.seizure.2014.11.006","volume":"24","author":"ES Yuen","year":"2015","unstructured":"Yuen ES, Troconiz IF (2015) Can pentylenetetrazole and maximal electroshock rodent seizure models quantitatively predict antiepileptic efficacy in humans? Seizure 24:21\u201327","journal-title":"Seizure"},{"key":"2505_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.seizure.2007.05.005","volume":"16","author":"SN Mandhane","year":"2007","unstructured":"Mandhane SN, Aavula K, Rajamannar T (2007) Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. Seizure 16:636\u2013644","journal-title":"Seizure"},{"key":"2505_CR30","first-page":"354","volume":"4","author":"SK Parmar","year":"2013","unstructured":"Parmar SK, Sharma TP, Airao VB, Bhatt R, Aghara R, Chavda S, Rabadiya SO, Gangwal AP (2013) Neuropharmacological effects of triterpenoids. Phytopharmacology 4:354\u2013372","journal-title":"Phytopharmacology"},{"key":"2505_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eplepsyres.2005.07.008","volume":"66","author":"BP Keogh","year":"2005","unstructured":"Keogh BP, Cordes D, Stanberry L, Figler BD, Robbins CA, Tempel BL, Green CG, Emmi A, Maravilla KM, Schwartzkroin PA (2005) BOLD-fMRI of PTZ-induced seizures in rats. Epilepsy Res 66:75\u201390","journal-title":"Epilepsy Res"},{"key":"2505_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.eplepsyres.2016.05.016","volume":"126","author":"W L\u00f6scher","year":"2016","unstructured":"L\u00f6scher W (2016) Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies. Epilepsy Res 126:157\u2013184","journal-title":"Epilepsy Res"},{"key":"2505_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1358\/mf.2009.31.2.1338414","volume":"31","author":"MM Castel-Branco","year":"2009","unstructured":"Castel-Branco MM, Alves GL, Figueiredo IV, Falcao AC, Caramona MM (2009) The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs. Methods Find Exp Clin Pharmacol 31:101\u2013106","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"2505_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4196\/kjpp.2014.18.5.441","volume":"18","author":"HS Bang","year":"2014","unstructured":"Bang HS, Seo DY, Chung YM, Oh KM, Park JJ, Arturo F, Jeong SH, Kim N, Han J (2014) Ursolic acid-induced elevation of serum irisin augments muscle strength during resistance training in men. Korean J Physiol Pharmacol 18:441\u2013446","journal-title":"Korean J Physiol Pharmacol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-018-2505-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-2505-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-2505-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T20:03:40Z","timestamp":1751486620000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-018-2505-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["2505"],"URL":"https:\/\/doi.org\/10.1007\/s11064-018-2505-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"27 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}